Comparison of biological properties of [177Lu]Lu-ProBOMB1 and [177Lu]Lu-NeoBOMB1 for GRPR targeting-Reference-Cited by-同舟云学术

Comparison of biological properties of [177Lu]Lu-ProBOMB1 and [177Lu]Lu-NeoBOMB1 for GRPR targeting

Published:2020-01-11 Issue:2 Volume:63 Page:56-64
ISSN:0362-4803
Container-title:Journal of Labelled Compounds and Radiopharmaceuticals
language:en
Short-container-title:J Label Compd Radiopharm

Author:

Rousseau Etienne¹^ORCID,Lau Joseph¹,Zhang Zhengxing¹,Zhang Chengcheng¹,Kwon Daniel¹,Uribe Carlos F.¹,Kuo Hsiou-Ting¹,Zeisler Jutta¹,Bratanovic Ivica¹,Lin Kuo-Shyan¹²^ORCID,Bénard François¹²

Affiliation:

1. Department of Molecular Oncology; BC Cancer Research Centre; Vancouver British Columbia Canada

2. Department of Radiology; University of British Columbia; Vancouver British Columbia Canada

Funder

BC Leading Edge Endowment Fund

Canadian Institutes of Health Research

Publisher

Wiley

Subject

Organic Chemistry,Spectroscopy,Drug Discovery,Radiology, Nuclear Medicine and imaging,Biochemistry,Analytical Chemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jlcr.3815/fullpdf

Reference24 articles.

1. Molecular basis for the selectivity of the mammalian bombesin peptide, neuromedin B, for its receptor;Gonzalez;J Pharmacol Exp Ther.,2009

2. Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy;Cornelio;Ann Oncol.,2007

3. Prospects of targeting the gastrin releasing peptide receptor and somatostatin receptor 2 for nuclear imaging and therapy in metastatic breast cancer;Dalm;PLoS One.,2017

4. Bombesin-like peptides and their receptors: recent findings in pharmacology and physiology;Guo;Curr Opin Endocrinol Diabetes Obes.,2015

5. Expression and function of gastrin-releasing peptide (GRP) in normal and cancerous urological tissues;Ischia;BJU Int.,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiopharmaceuticals Targeting Gastrin-Releasing Peptide Receptor for Diagnosis and Therapy of Prostate Cancer;Molecular Pharmaceutics;2024-08-06

2. Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer;Advanced Pharmaceutical Bulletin;2023-04-29

3. GRPr Theranostics: Current Status of Imaging and Therapy using GRPr Targeting Radiopharmaceuticals;Nuklearmedizin - NuclearMedicine;2022-06

4. Implications of physics, chemistry and biology for dosimetry calculations using theranostic pairs;Theranostics;2022

5. A Novel Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor Positive Prostate Cancer;Journal of Nuclear Medicine;2021-07-22